Yara İyileşmesi ve D Vitamini
Özet
Yara iyileşmesi; inflamasyon, yeni doku oluşumu ve yeniden şekillenme aşamalarından oluşan karmaşık bir biyolojik süreçtir. D vitamininin bu süreçteki rolü tam açıklığa kavuşmamış olsa da anti-inflamatuar, anti-proliferatif ve antimikrobiyal özellikleri ile iyileşmeye katkı sağladığı bilinmektedir. 1,25(OH)2D3; makrofajların kemotaktik ve fagositik tepkilerini artırırken, proinflamatuar sitokinleri baskılamakta ve yara iyileşmesini destekleyen Th-2 sitokinlerinin üretimini uyarmaktadır. Ayrıca epidermisteki D vitamini reseptörleri (VDR), keratinosit farklılaşmasını destekleyerek epidermal bariyer oluşumunu düzenler. Klinik çalışmalarda; yanık yaraları, venöz ülserler, bası ülserleri ve diyabetik ayak ülserleri olan hastalarda D vitamini eksikliğinin yüksek oranlarda görüldüğü; düşük D vitamini seviyelerinin yara iyileşme süresini uzattığı ve yara alanını genişlettiği saptanmıştır. Hayvan modellerinde ve in vitro çalışmalarda, topikal ve sistemik D vitamini takviyelerinin, kalsipotriolün ve fibronektin sentezinin uyarılmasının yara kapanmasını hızlandırdığı, enflematuar yanıtı azalttığı ve iyileşmeyi desteklediği gösterilmiştir. Sonuç olarak, D vitamininin yara iyileşmesinin farklı aşamalarında kritik rolleri bulunmakta olup kronik yaraların tedavisinde alternatif bir seçenek olarak kullanılabilmesi için daha fazla klinik çalışmaya, doz ve süre belirlenmesine ihtiyaç duyulmaktadır.
Wound healing is a complex biological process consisting of inflammation, new tissue formation, and remodeling phases. Although the exact role of vitamin D in this process is not fully elucidated, it is known to contribute to healing through its anti-inflammatory, anti-proliferative, and antimicrobial properties. 1,25(OH)2D3 enhances the chemotactic and phagocytic responses of macrophages, suppresses pro-inflammatory cytokines, and stimulates the production of Th-2 cytokines that support wound healing. Additionally, vitamin D receptors (VDR) in the epidermis regulate epidermal barrier formation by promoting keratinocyte differentiation. Clinical studies have revealed high rates of vitamin D deficiency in patients with burn wounds, venous ulcers, pressure ulcers, and diabetic foot ulcers, showing a negative correlation where low vitamin D levels prolong healing time and increase wound size. In animal models and in vitro studies, topical and systemic vitamin D supplementation, calcipotriol, and the stimulation of fibronectin synthesis have been shown to accelerate wound closure, reduce the inflammatory response, and promote healing. Consequently, while vitamin D plays critical roles in various stages of wound healing, more studies are required to determine its efficacy, dosage, and duration for alternative use in chronic wound treatment.
Referanslar
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314-21.
Rodero MP, Khosrotehrani K. Skin wound healing modulation by macrophages. Int J Clin Exp Pathol. 2010;3(7):643-53.
Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601.
Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313-26.
Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol. 2001;69(4):513-21.
O’Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol. 1997;29(1):63-78.
Abe E, Shiina Y, Miyaura C, et al. Activation and fusion induced by 1 alpha,25-dihydroxyvitamin D3 and their relation in alveolar macrophages. Proc Natl Acad Sci U S A. 1984;81(22):7112-6.
Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol. 1986;98(2):311-22.
Dam TN, Møller B, Hindkjaer J, Kragballe K. The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin. J Investig Dermatol Symp Proc. 1996;1(1):72-7.
Rigby WF, Waugh MG. Decreased accessory cell function and costimulatory activity by 1,25-dihydroxyvitamin D3-treated monocytes. Arthritis Rheum. 1992;35(1):110-9.
Etten E van, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. The Journal of Steroid Biochemistry and Molecular Biology. 2005;97(1-2):93-101.
Dorschner RA, Pestonjamasp VK, Tamakuwala S, et al. Cutaneous Injury Induces the Release of Cathelicidin Anti-Microbial Peptides Active Against Group A Streptococcus. Journal of Investigative Dermatology. 2001;117(1):91-7.
Heilborn JD, Weber G, Grönberg A, et al. Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo. Experimental Dermatology. 2010;19(4):332-8.
Bikle DD, Pillai S, Gee E, Hincenbergs M. Regulation of 1,25-Dihydroxyvitamin D Production in Human Keratinocytes by Interferon-γ*. Endocrinology. 1989;124(2):655-60.
Luderer HF, Nazarian RM, Zhu ED, Demay MB. Ligand-Dependent Actions of the Vitamin D Receptor Are Required for Activation of TGF-β Signaling during the Inflammatory Response to Cutaneous Injury. Endocrinology. 2013;154(1):16-24.
Lansdown ABG. Calcium: a potential central regulator in wound healing in the skin. Wound Repair and Regeneration. 2002; 10(5):271-85.
Bikle DD. Vitamin D regulated keratinocyte differentiation. J Cell Biochem. 2004;92(3):436-44.
Ramesh KV, Mahindrakar MB, Bhat EP. A new role for vitamin D: cholecalciferol promotes dermal wound strength and re-epithelization. Indian J Exp Biol. 1993;31(9):778-9.
Tian XQ, Chen TC, Holick MF. 1,25-dihydroxyvitamin D3: a novel agent for enhancing wound healing. J Cell Biochem. 1995;59(1):536.
Gamady A, Koren R, Ron D, et al. Vitamin D enhances mitogenesis mediated by keratinocyte growth factor receptor in keratinocytes. J Cell Biochem. 2003;89(3):440-9.
Gurlek A, Pittelkow MR, Kumar R. Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev. 2002;23(6):763-86.
Brown LF, Dubin D, Lavigne L, et al. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol. 1993;142(3):793-801.
Fransson J, Hammar H. Epidermal growth in the skin equivalent. Arch Dermatol Res. 1992;284(6):343-8.
Cheng CY, Martin DE, Leggett CG, et al. Fibronectin enhances healing of excised wounds in rats. Arch Dermatol. 1988;124(2):221-5.
Nagelschmidt M, Becker D, Bonninghoff N, Engelhardt GH. Effect of Fibronectin Therapy and Fibronectin Deficiency on Wound Healing: A Study in Rats. The Journal of Trauma: Injury, Infection, and Critical Care. 1987;21(11):1267-71.
Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, vd. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D–dependent mechanism. J Clin Invest. 2007;117(3):803-11.
Cho YS, Seo CH, Joo SY, Ohn SH. The association between vitamin D levels and burn factors in different burn types. Burns Trauma. 2020;8:018.
Burkievcz CJC, Skare TL, Malafaia O, et al. Vitamin D deficiency in patients with chronic venous ulcers. Rev Col Bras Cir. 2012;39(1):60-3.
Lussi C, Frotzler A, Jenny A, et al. Nutritional blood parameters and nutritional risk screening in patients with spinal cord injury and deep pressure ulcer-a retrospective chart analysis. Spinal Cord. 2018;56(2):168-75.
Otero TMN, Canales C, Yeh DD, et al. Vitamin D Status Is Associated With Development of Hospital-Acquired Pressure Injuries in Critically Ill Surgical Patients. Nutr Clin Pract. 2019;34(1):142-7.
Kalava UR, Cha SS, Takahashi PY. Association between vitamin D and pressure ulcers in older ambulatory adults: results of a matched case-control study. Clin Interv Aging. 2011;6:213-9.
Afarideh M, Ghanbari P, Noshad S, et al. Raised serum 25-hydroxyvitamin D levels in patients with active diabetic foot ulcers. Br J Nutr. 2016;115(11):1938-46.
Çağlar S, Çağlar A, Pilten S, ve ark. Osteoprotegerin and 25-hydroxy vitamin D levels in patients with diabetic foot. Eklem Hastalik Cerrahisi. 2018;29(3):170-5.
Dai J, Jiang C, Chen H, Chai Y. Vitamin D and diabetic foot ulcer: a systematic review and meta-analysis. Nutr Diabetes. 2019;9(1):8.
Razzaghi R, Pourbagheri H, Momen-Heravi M, et al. The effects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. Journal of Diabetes and its Complications. 2017;31(4):766-72.
Gonzalez-Curiel I, Trujillo V, Montoya-Rosales A, et al. 1,25-Dihydroxyvitamin D3 Induces LL-37 and HBD-2 Production in Keratinocytes from Diabetic Foot Ulcers Promoting Wound Healing: An In Vitro Model. Harder J, editör. PLoS ONE. 2014;9(10):e111355.
Tian XQ, Chen TC, Holick MF. 1,25-Dihydroxyvitamin D3: A novel agent for enhancing wound healing. J Cell Biochem. 1995;59(1):53-6.
Yuan Y, Das SK, Li M. Vitamin D ameliorates impaired wound healing in streptozotocin-induced diabetic mice by suppressing NF-κB-mediated inflammatory genes. Bioscience Reports. 2018;38(2):BSR20171294.
Wang D, Lin L, Lei K, et al. Vitamin D3 analogue facilitates epithelial wound healing through promoting epithelial-mesenchymal transition via the Hippo pathway. Journal of Dermatological Science. 2020;100(2):120-8.
